Literature DB >> 19276996

Tapering versus cold turkey: symptoms versus successful discontinuation of menopausal hormone therapy.

Jo-Anne Suffoletto, Rachel Hess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19276996      PMCID： PMC2758567          DOI： 10.1097/gme.0b013e3181a057db

Source DB:  PubMed          Journal:  Menopause        ISSN： 1072-3714            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  A 60-year-old woman trying to discontinue hormone replacement therapy.

Authors:  Deborah Grady
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

2.  Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

3.  Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study.

Authors:  Ronit Haimov-Kochman; Edyah Barak-Glantz; Revital Arbel; Miriam Leefsma; Amnon Brzezinski; Ariel Milwidsky; Drorith Hochner-Celnikier
Journal:  Menopause       Date:  2006 May-Jun       Impact factor: 2.953

Review 4.  A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2000 Mar-Apr       Impact factor: 2.953

5.  How best is to discontinue postmenopausal hormone therapy: immediate or tapered?

Authors:  Erdogan Aslan; Tayfun Bagis; Esra Bulgan Kilicdag; Ebru Tarim; Serkan Erkanli; Esra Kuscu
Journal:  Maturitas       Date:  2006-10-13       Impact factor: 4.342

6.  Symptom experience after discontinuing use of estrogen plus progestin.

Authors:  Judith K Ockene; David H Barad; Barbara B Cochrane; Joseph C Larson; Margery Gass; Sylvia Wassertheil-Smoller; JoAnn E Manson; Vanessa M Barnabei; Dorothy S Lane; Robert G Brzyski; Milagros C Rosal; Judy Wylie-Rosett; Jennifer Hays
Journal:  JAMA       Date:  2005-07-13       Impact factor: 56.272

7.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

8.  Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?

Authors:  Sally G Haskell; Bevanne Bean-Mayberry; Kirsha Gordon
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

9.  Predictors of difficulty when discontinuing postmenopausal hormone therapy.

Authors:  Deborah Grady; Bruce Ettinger; Anna N A Tosteson; Alice Pressman; Judith L Macer
Journal:  Obstet Gynecol       Date:  2003-12       Impact factor: 7.661

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.